Hazard
80 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 80 defective delivery system recalls we have scored against our rubric, 1 (1%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 12 (15%) are Severe.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all defective delivery system recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Novo Nordisk is recalling 71,215 GlucaGen HypoKits because the syringe needles may be detached. The recall covers lots expiring in September 2017.
Sandoz Inc is recalling 42,740 cartons of Transderm Scop (scopolamine) transdermal systems in Tennessee due to a defective delivery system that may alter drug release.
Biocompatibles is recalling Varithena administration packs because they contain the incorrect type of syringe. The recall covers 3,254 packs distributed nationwide.
Noven Pharmaceuticals is recalling 7,850 boxes of Daytrana (methylphenidate) transdermal patches because the release liner may be difficult to remove.
Noven Pharmaceuticals is recalling 2,088 boxes of Daytrana transdermal patches because the release liner may be difficult to remove.
Sanofi-Aventis is recalling 159,000 Auvi-Q epinephrine auto-injectors nationwide because a defective delivery system may result in inaccurate dosage delivery.
Sanofi-Aventis is recalling Auvi-Q epinephrine auto-injectors because a defective delivery system may result in inaccurate dosage delivery.
Lymol Medical is recalling Sclerosol Intrapleural Aerosol because a defective stem valve may cause the canister to leak propellant, resulting in no drug or an inadequate dose being delivered.
AstraZeneca is recalling Tudorza Pressair inhalers because some units have actuation counters set to a number other than 60.
GlaxoSmithKline is recalling Ventolin HFA inhalers because some may not deliver the full 200 actuations labeled on the canister.
Noven Pharmaceuticals is recalling Daytrana (methylphenidate) 30 mg patches due to a defective delivery system that failed mechanical peel force specifications.
Boehringer Ingelheim is recalling 358,647 Combivent Respimat inhalers because the delivery system may fail to spray properly.
Noven Pharmaceuticals is recalling 125,340 Daytrana patches because one lot exceeded the mechanical peel specification. The recall is nationwide.
Noven Pharmaceuticals is recalling 160,800 Daytrana patches because the adhesive release liner may be difficult to remove.
Teva Pharmaceuticals is recalling QVAR inhalation aerosol canisters because the delivery system and valve are defective.
Noven Pharmaceuticals is recalling Daytrana (methylphenidate) transdermal patches because out-of-specification results indicate the release liner may be difficult to remove.
Noven Pharmaceuticals is recalling 187,860 Daytrana patches because the release liner may be difficult to remove. The defect affects the ability to apply the patch correctly.
Teva Pharmaceuticals USA is recalling Qnasl Nasal Aerosol units because some may have clogged stem valves, potentially affecting delivery.
L. Perrigo Co. is recalling 143,892 bottles of infants' acetaminophen suspension because some may be packaged with dosing syringes lacking dose markings.
Noven Pharmaceuticals is recalling Daytrana (methylphenidate) transdermal patches because the release liner may be difficult to remove.
Genentech is recalling 10,306 syringes of Nutropin AQ NuSpin 20 because the dose knob may spin slowly, causing delayed injection delivery.
Genentech is recalling 12,791 syringes of Nutropin AQ NuSpin 10 because the dose knob may spin slowly, causing delayed injection delivery.
Noven Pharmaceuticals is recalling 177,900 Daytrana (methylphenidate) patches because the delivery system may be miscalibrated or defective, potentially affecting the removal of the release liner.
Noven Pharmaceuticals is recalling 231,270 Daytrana patches because the release liner may be difficult to remove.
Noven Pharmaceuticals is recalling 121,530 Daytrana patches because the release liner may be difficult to remove. The defect affects the patch's mechanical peel force.